Nuovo Ospedale degli Infermi

Ponderano 13875

1 studies enrolling now · 2 studies all time

What they study most

Fallopian Tube Cancer, Ovarian Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early